Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...

The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.

The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.

Saga PLC - Kent, England-based provider of products and services for people over 50 - Announces that its 20-year motor and home insurance partnership with Ageas UK, wholly-owned subsidiary of Ageas SA ...

In a corner of a national park where the ground steams and the air smells faintly of sulfur, scientists have stumbled on a ...

For years, the storage industry has relied on familiar assumptions with falling prices, rising density, and steady gains ...

The first contract was signed with the Chinese group Shen Feng Ming and includes the establishment of an integrated complex ...

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

RNA-expression patterns in the tips of the weevils’ antennae suggests that these organs produce a protein known to help other ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

It's been a tough stretch for Saquon Barkley recently, and it's time to consider him just a No. 2 Fantasy running back in the majority of leagues. You're still starting him in most formats, but he's ...